Reinventing Drug Discovery, from Retrospective to Perspectives

10th NovAliX Conference - Anniversary Edition

 Brunnen, Switzerland    June 2-4, 2024

Financial Perspectives on the Future of the Industry

Title of talk to be announced

Mrs Magali RICHARD
HOME BIOSCIENCES, Paris, France

Vision for the Future of Drug Discovery

Title of talk to be announced

Dr Claude BERTRAND
INSTITUT DE RECHERCHES SERVIER, GIF-SUR-YVETTE, France

Title of talk to be announced

Dr Karin BRINER
GENENTECH, South San Francisco, United States

25 Years of Thinking Small

Dr Harren JHOTI
ASTEX PHARMACEUTICALS, Cambridge, United Kingdom

Adding Years of Life and Quality of Life: How the Healthcare Industry Can Bring Value to the World

Dr Paul STOFFELS
GALAPAGOS, Beerse, Belgium

Present and Future Tools for Drug Discovery

The SGC over 20 Years: Open Experimental Data, Knowledge and Reagents Enabling Drug Discovery

Prof. Cheryl ARROWSMITH
STRUCTURAL GENOMICS CONSORTIUM, Toronto, Canada

Title of talk to be announced

Dr Maria M. FLOCCO
ASTRAZENECA, Cambridge, United Kingdom

Title of talk to be announced

Prof. Andrew HOPKINS
, Oxford, United Kingdom

Title of talk to be confirmed

Prof. Holger STARK
MAX PLANCK INSTITUTE FOR MULTIDISCIPLINARY SCIENCES, Göttingen, Germany

New Modalities as New Frontiers of Drug Discovery

Biophysics for Protein Degraders: It’s all in the Ternary Complex

Prof. Alessio CIULLI
UNIVERSITY OF DUNDEE, Dundee, United Kingdom

Chance Favors the Perplexed Mind: The Critical Role of Biochemistry and Biophysics in the Development of Small Molecule Inhibitors of Chromatin- and RNA-Modifying Enzymes as Precision Cancer Therapeutics

Dr Robert COPELAND
ACCENT THERAPEUTICS, INC., Lexington, United States

Induced Proximity: Exploring New Therapeutic Modalities

Prof. Craig CREWS
YALE UNIVERSITY, New Haven, CT, United States

Unmet Therapeutic Needs : Current Challenges

Building a Pipeline of High-Impact Products to Prevent, Diagnose and Treat Bacterial Infections

Dr Erin DUFFY
CARB-X, Boston, United States

Challenges and Opportunities in Cancer Therapy: a Perspective Across Modalities

Dr Tobias SCHMELZLE
NOVARTIS, Basel, Switzerland
Read more

Round table Contributors

Dr Chun-wa CHUNG
GLAXOSMITHKLINE, Stevenage, United Kingdom

Prof. Helena DANIELSON
UPPSALA UNIVERSITY, Uppsala, Sweden

Dr Matthias FRECH
MERCK, Darmstadt, Germany

Dr Stefan GESCHWINDNER
ASTRAZENECA, Mölndal, Sweden

Dr Sylwia HUBER
F. HOFFMANN-LA ROCHE, Basel, Switzerland

Dr Sandra JACOB
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Basel, Switzerland

Dr Herbert NAR
BOEHRINGER INGELHEIM, Biberach, Germany